OrganOx Revenue and Competitors

Oxford,

Location

#1396

Growjo Ranking

Estimated Revenue & Valuation

  • OrganOx's estimated annual revenue is currently $30.1M per year.(i)
  • OrganOx's estimated revenue per employee is $251,000

Employee Data

  • OrganOx has 120 Employees.(i)
  • OrganOx grew their employee count by 94% last year.

OrganOx's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP North America OperationsReveal Email/Phone
3
VP Clinical EngagementReveal Email/Phone
4
Quality OfficerReveal Email/Phone
5
Global Director Quality and Regulatory AffairsReveal Email/Phone
6
Director Clinical Support, North AmericaReveal Email/Phone
7
Director, Training & EducationReveal Email/Phone
8
Director Sales, North AmericaReveal Email/Phone
9
Marketing DirectorReveal Email/Phone
10
Global Commercial DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is OrganOx?

"Living Organs For Life" Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation involves storage of the liver at 4˚C, using a non-physiological perfusion solution that aims to minimise liver decay. By contrast, warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition. The liver is therefore functional during the preservation period, producing bile, metabolizing glucose and maintaining a physiological pH. This enables objective assessment of organ performance prior to transplant, extended preservation times, and the potential use of organs that are presently being discarded.

keywords:N/A

N/A

Total Funding

120

Number of Employees

$30.1M

Revenue (est)

94%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OrganOx News

2022-04-19 - Organ Preservation Market Size, Scope And Forecast ...

... Dr. Franz K hler Chemie GmbH, XVIVO Perfusion AB, Organox Limited, Shanghai Genext Medical Technology, Waters Medical Systems.

2022-04-06 - LifeShare celebrates Donate Life Month | Community

LifeShare Oklahoma partners with OrganOx and Ochre Bio to study perfusion technology that sustains livers outside a donor's body.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M12472%N/A
#2
$26M124-6%N/A
#3
$18.1M12520%N/A
#4
$15M12515%N/A
#5
$34M12624%N/A